On Invalid Date, Titan Pharmaceuticals (NASDAQ: TTNP) reported Q3 2023 earnings per share (EPS) of -$0.40, up 88.89% year over year. Total Titan Pharmaceuticals earnings for the quarter were -$338.00 thousand. In the same quarter last year, Titan Pharmaceuticals's earnings per share (EPS) was -$3.60.
As of Q1 2024, Titan Pharmaceuticals's earnings has grown year over year. Titan Pharmaceuticals's earnings in the past year totalled -$6.17 million.
What was TTNP's revenue last quarter?
On Invalid Date, Titan Pharmaceuticals (NASDAQ: TTNP) reported Q3 2023 revenue of $4.00 thousand up 95.79% year over year. In the same quarter last year, Titan Pharmaceuticals's revenue was $95.00 thousand.
What was TTNP's revenue growth in the past year?
As of Q1 2024, Titan Pharmaceuticals's revenue has grown -46.5% year over year. This is 212.11 percentage points lower than the US Biotechnology industry revenue growth rate of 165.61%. Titan Pharmaceuticals's revenue in the past year totalled $306.00 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.